54 Results
Sort By:
Published on February 18, 2022
Researchers at the University of Edinburgh have discovered that early use of antibiotics in newborns can cause harm to the microbiome, potentially resulting in an adverse impact on later health, so they advise caution when prescribing these drugs to young babies. In a study of 227 babies in their first…
Published on January 11, 2022
Israel-based immune response diagnostics company MeMed announced Monday it had closed a $93 million private financing round. Proceed will be used to build manufacturing capacity, accelerate commercialization of its diagnostic kits and platform, and to broaden the company’s product lines. In total, MeMed has raised more than $200 million including…
Published on September 13, 2021
Oxford Nanopore, the pioneer developer of DNA/RNA nanopore sensing tools that include its pocket-sized MinION DNA/RNA sequencer, has disclosed plans for an initial public offering that could value the company at a reported £4 billion ($5.5 billion). Oxford Nanopore seeks to trade its shares on the London Stock Exchange. “Ever…
Published on August 25, 2021
Back in 2015, when Bill Gates famously declared we were “not ready for the next outbreak,” few people could have predicted how true his words would be and what kind of global impact that next outbreak would have. But the COVID-19 pandemic has not only altered most of our lives…
Published on June 24, 2021
A small handheld device the size of a USB stick, developed by researchers at McMaster University in Canada, can accurately detect bacterial urinary tract infections in minutes after analyzing a droplet of urine. The electronic device works in a similar way to a blood-glucose monitor and also has the potential…
Published on February 4, 2020
Studies by an international research team suggest that rates of disease caused by the bacterium Streptococcus pneumoniae could be substantially reduced by changing how vaccines are designed. The scientists, at the Wellcome Sanger Institute, Simon Fraser University in Canada, and Imperial College London combined genomic data, models of bacterial evolution,…
Published on January 29, 2020
Guochun Liao, Ph.D., founder, president, and CEO of IDbyDNA IDbyDNA, the developer of a next-generation sequencing (NGS)-based metagenomics platform designed to simultaneously detect and analyze tens of thousands of microorganisms and pathogens in any sample, said it has raised $20 million in Series B financing. Proceeds…
Published on November 15, 2019
Molecular diagnostics company Inflammatix has announced a $6 million cost sharing contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response to further develop its HostDx tests. The contract could eventually be worth up $72 million based…
Published on November 5, 2019
Ares Genetics, a subsidiary of molecular microbiology diagnostics and syndromic testing company Curetis, has launched an early access program for its molecular antibiotic susceptibility test (AST), that leverages next-generation sequencing (NGS) and artificial intelligence (AI) technologies. According to the company, the new test has multiple applications ranging from identifying antibiotic…
Published on September 6, 2019
OpGen and Curetis said they will merge into a transatlantic diagnostics developer focused on molecular diagnostics and bioinformatics, with a pipeline of diagnostics specializing in infectious diseases and antimicrobial resistance (AMR). The combined company will market a commercial-stage diagnostics portfolio of CE-IVD-marked and FDA-cleared products and platforms, plus proprietary NGS-based…
Published on February 22, 2019
QIAGEN has acquired from Ares Genetics an exclusive license to use its ARESdb proprietary antimicrobial resistance (AMR) database, as well as bioinformatics tools and workflows from the ARES Technology Platform, called AREStools. The value of the licenses was not disclosed. The database, tools, and workflows will be integrated into QIAGEN’s…
Published on January 28, 2019
Antibiotic-resistant genes (ARGs) that were first detected in urban India have been found 8,000 miles away in one of the last pristine places on earth, reported a new study (“Understanding drivers of antibiotic resistance genes in High Arctic soil ecosystems”) published in Environmental International. Soil samples taken in the Kongsfjorden region…
Published on July 27, 2018
Culminating nearly two years of behind-the-scenes development work, Arc Bio this week introduced its first product, Galileo AMR an antimicrobial resistance software, that the company says will be the first of a series of next-gen sequencing based tools focused on pathogen detection. “At Arc Bio, we are on a mission…
Published on April 11, 2017
A research team led by Huimin Zhao, Ph.D., a chemical and biomolecular engineering professor at the University of Illinois at Urbana-Champaign, reports that they have now unlocked new potential formerly hidden in silent genes, using CRISPR/Cas9 gene-editing technology. Dr. Zhao and colleagues, including researchers from Singapore’s Agency for Science, Technology,…
Published on October 19, 2023
Researchers have created a genome-wide metabolic model of the bacterium responsible for Lyme disease, which could help create more bespoke treatments and avoid the need for broad-spectrum antibiotics. The computational “subway map” of Borrelia burgdorferi makes it possible to identify potential drug targets and existing treatments that act only upon…